New Intravenous Antibiotic For MRSA Superbug Approved By FDA

New MRSA Antibiotic

An intravenous cephalosporin antibiotic called Ceftaroline has been approved for treating community- acquired bacterial pneumonia and for acute bacterial skin and skin structure infections, including methicillin-resistant Staphylococcus aureus, the Food and Drug Administration announced on Oct. 29.

The approved prescribing information of ceftaroline states that it is indicated for:
1.) The treatment of community-acquired bacterial pneumonia (CABP) caused by susceptible isolates of the following gram-positive and gram-negative microorganisms: Streptococcus pneumoniae (including cases with concurrent bacteremia), Staphylococcus aureus (methicillin-susceptible isolates only), Haemophilus influenzae, Klebsiella pneumoniae, Klebsiella oxytoca, and Escherichia coli.

2.) The treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following gram-positive and gram-negative micro-organisms: Staphylococcus aureus (including methicillin-susceptible and -resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca.

Approval was based on four phase III studies of patients aged 18 years and older. In the two studies of 1,231 patients with CABP, the effectiveness of treatment with ceftaroline was found to be comparable to that of ceftriaxone (Rocephin), the comparator drug, in the studies, according to the FDA statement announcing the approval. In the two studies of almost 1,400 patients with ABSSSIs, treatment with ceftaroline was found to be comparable to that of the combination of vancomycin (Vancocin) and aztreonam (Azactam). Diarrhea, nausea, and rash are among the most commonly reported side effects associated with ceftaroline, according to the FDA. At a meeting in September, an FDA advisory panel backed the approval of the drug for these two indications.

Ceftaroline will be marketed as Teflaro by Forest Laboratories Inc. The company plans to have the drug available in January 2011.    CONTINUE READING…

Free Telephone Consultations

If you wish to discuss how you can get your life back without Morgellons, call our toll-free number and our experienced (4+ years working directly with Morgellons victims) counselors will help you through this nightmare.  We have seen thousands of Morgellons victims recover.  It is your turn now, so pick up your telephone and call this number now.

888-240-2326 Option #2



Bookmark & Share

Advertisements

About CareMan
I am the CareMan, have been for 7 years now. I really do care about YOU and getting YOU back to great, natural health, so long as you have an open mind.

2 Responses to New Intravenous Antibiotic For MRSA Superbug Approved By FDA

  1. julie kurtzman bott says:

    Thank you for you information. I live in SouthEast Ohio and suffer from Morgellons.

    • CareMan says:

      Julie,

      Why not try NutraSilver? It really works and you can end your suffering. think about it, OK?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: